Rheumatism patients in methotrexate therapy have lower mortality if their vitamin D levels are high
Vitamin D deficiency is a common problem among patients with rheumatoid arthritis. However, if their blood levels of vitamin D are high before they start on methotrexate therapy, it lowers their mortality. This was shown in a study published in Nutrients, where the authors looked at vitamin D’s therapeutic properties. Note that the official vitamin D recommendations are too low to optimize blood levels of the nutrient.